menu

Licensing opportunities 

A number of opportunities that are available for commercial (co-)development. The flyer containing more information can be downloaded below. 

Multiwell In Vitro In Vivo
This multiwell High Throughput Screening (HTS) approach embodies a practical strategy which features some unique selling points. 

Treating Cognitive Impairment with Roflumilast
Two patent applications (roflumilast in monotherapy and roflumilast in combination therapy with acetylcholinesterase inhibitors) have been filed by Maastricht University and are available for licensing. Maastricht University is searching for partner(s) to complete development and commercialization

If you are interested in any of these opportunities, please get in touch with the contact person referred to on the specific flyer.

Multiwell In Vitro In Vivo

Download here

Treating Cognitive Impairment

Download here